Dural Metastasis with Subdural Hemorrhage from Prostate Cancer
International Journal of Neurologic Physical Therapy
Volume 3, Issue 6, December 2017, Pages: 49-53
Received: Aug. 13, 2017; Accepted: Aug. 28, 2017; Published: Dec. 18, 2017
Views 1535      Downloads 87
Authors
Kantenga Dieu Merci Kabulo, Department of Neurosurgery, University of Zimbabwe, Harare, Zimbabwe
Nathaniel Harunangoni Zimani, Department of Neurosurgery, University of Zimbabwe, Harare, Zimbabwe
Aaron Masiiwe Musara, Department of Neurosurgery, University of Zimbabwe, Harare, Zimbabwe
Patrice Ntenga, Neurological Clinic of the National Teaching Hospital-FANN, Dakar, Senegal
Khita Phiri, Department of Pathology, University of Zimbabwe, Harare, Zimbabwe
Kazadi Kaluile Ntenga Kalangu, Department of Neurosurgery, University of Zimbabwe, Harare, Zimbabwe
Rudo Makunike Mutasa, Department of Pathology, University of Zimbabwe, Harare, Zimbabwe
Article Tools
Follow on us
Abstract
A subdural hematoma (SDH) is usually traumatic in etiology. Non-traumatic instances of SDH are uncommon, and are rarely due to metastases involving the dura. We report a 68-year-old male patient with a one day history of, not communicating and not mobilizing and a 2 weeks history of generalized body weakness. A computed tomography (CT) scan revealed a left sided hypo-dense subdural collection. A diagnosis of left sided chronic subdural hematoma (SDH) was made. Burr hole drainage of the hematoma was performed. Intra- operatively, liquefied blood was drained and a thick dura with reddish material infiltrating the dura was noted. A specimen of the dura was submitted for histology and revealed metastatic carcinoma, confirmed at immunohistochemistry to be of prostatic origin. Conclusion: Metastatic disease should be considered when there is a chronic subdural hematoma with no history of trauma and an unusual dural appearance on imaging.
Keywords
Prostate Cancer, Dural Metastases, Subdural Hematoma
To cite this article
Kantenga Dieu Merci Kabulo, Nathaniel Harunangoni Zimani, Aaron Masiiwe Musara, Patrice Ntenga, Khita Phiri, Kazadi Kaluile Ntenga Kalangu, Rudo Makunike Mutasa, Dural Metastasis with Subdural Hemorrhage from Prostate Cancer, International Journal of Neurologic Physical Therapy. Vol. 3, No. 6, 2017, pp. 49-53. doi: 10.11648/j.ijnpt.20170306.11
Copyright
Copyright © 2017 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
[1]
Kleinschmidt-DeMasters BK: Dural metastases. A retrospective surgical and autopsy series. Arch Pathol Lab Med 125: 880–887, 2001.
[2]
McKenzie CR, Rengachary SS, McGregor DH, Dixon AY, Suskind DL: Subdural hematoma associated with metastatic neoplasms. Neurosurgery 27: 619–624; discussion 624–625, 1990.
[3]
Meyer P C, Reah T G. Secondary neoplasms of the central nervous system and meninges. Br J Cancer. 1953; 7(4): 438–448.
[4]
Soto-Ares G, Denes M, Noule N, Vinchon M, Pruvo JP, Gosset D. Subdural hematomas in children: role of cerebral and spinal MRI in the diagnosis of child abuse. J Radiol. 2003 Nov; 84(11 Pt 1): 1757-65.
[5]
Laigle-Donadey F, Taillibert S, Mokhtari K, Hildebrand J, Delattre J Y. Dural metastases. J Neurooncol. 2005; 75(1): 57–61.
[6]
Benjamin R, Neurologic complications of prostate cancer, Am Fam Physician. 2002 May 1; 65(9): 1834-40.
[7]
Tremont-Lukats et al. Brain metastasis from prostate carcinoma: The M. D. Anderson Cancer Center Experience. Cancer 2003; 98: 363–368.
[8]
Bobustuc G, Lagos G K, Lolas K, Kyritsis A P, Puduvalli V K. Brain metastasis from prostate carcinoma: The M. D. Anderson Cancer Center experience. Cancer. 2003; 98(2): 363–368.
[9]
Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, Jain RK, McDonald DM. Openings between defective endothelial cells explain tumor vessel leakiness. American Journal of Pathology 2000; 156: 1363-1380.
[10]
De la Fouchardiere C, Flechon A. Droz JP. Coagulopathy in prostate cancer. Netherlands. The Journal of Medicine. 2003; 61(11): 347-354.
[11]
O’Meara C, Mahasneh T, Wilson P, I’Ons B, Alkhawaja D. Dural prostate metastasis resembling a chronic subdural haematoma. JSCR 2012 5: 7.
[12]
Rumana CS, Hess HR, Shi WM, Sawaya R. Metastatic brain tumors with Dural extension. J Neurosurg 1998; 89; 552-558.
[13]
Benjamin R, Neurologic complications of prostate cancer, Am Fam Physician. 2002 May 1; 65(9): 1834-40.
[14]
Balm M, Hammack J. Leptomeningeal carcinomatosis. Presenting features and prognostic factors. Arch Neurol 1996; 53: 6 26-32.
[15]
DeAngelis LM. Metastatic disease of the nervous system. Curr Treat Options Neurol 1999; 1: 409-16.
[16]
J. L. Navarro-Olvera∗, E. Ari˜nez-Barahona, M. A. Esqueda-Liquidano, A. Mu˜noz-Cobos, Brain metastases: Literature review, Rev Med Hosp Gen Méx. 2017; 80(1): 60---66.
[17]
Wolff JM, Bares R, Jung PK, Buell U, Jakse G. Prostate-specific antigen as a marker of bone metastasis in patients with prostate cancer. Urol Int 1996; 56: 169-73.
[18]
Glantz MJ, Cole BF, Forsyth PA, Recht LD, Wen PY, Chamberlain MC, et al. Practice parameter: anticonvulsant prophylaxis in patients with newly Diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000; 54: 1886-93.
[19]
Micali G, Linthicum K, Han N, West DP. Increased risk of erythema multiforme major with combination anticonvulsant and radiation therapies. Pharmacotherapy 1999; 19: 223-7.
[20]
Gupta A, Baidas S, Cumberlin RK. Brain stem metastasis as the only site of spread in prostate carcinoma. A case report. Cancer 1994; 74: 2516-9.
[21]
Patchell RA. The treatment of brain metastases. Cancer Invest 1996; 14: 169-77.
[22]
Deepak Khuntia, Contemporary Review of the Management of Brain Metastasis with Radiation Hindawi Publishing Corporation Advances in Neuroscience Volume 2015, Article ID 372856, 13 pages.
[23]
Ajay Niranjan, MD, MBA and L. Dade Lunsford, MD, Gamma Knife Radiosurgery for 5 to 10 Brain Metastases: A Good Option for Upfront Treatment, Oncology Journal, Brain Tumors, April 15, 2016, Oncology (Williston Park). 30(4): 314–315, 317.
[24]
Fervenza FC, Wolanskyj AP, Eklund HE, Richardson RL. Brain metastasis: an unusual complication from prostatic adenocarcinoma. Mayo Clinic Proc 2000; 75: 79-82.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186